(Q42997648)

12 November 2017

Influence of HCV or HBV coinfection on adverse drug reactions to antiretroviral drugs in HIV patients (English)

1 reference

12 November 2017

Maryse Lapeyre-Mestre

3

1 reference

PubMed ID

16416303

Emmanuelle Bondon-Guitton

12 November 2017

object named as

Emmanuelle Guitton

1

0 references

Jean-Louis Montastruc

2

object named as

Jean-Louis Montastruc

1 reference

12 November 2017

French Network of Pharmacovigilance Centres

4

1 reference

12 November 2017

17 January 2006

1 reference

European Journal of Clinical Pharmacology

12 November 2017

1 reference

12 November 2017

62

1 reference

12 November 2017

3

1 reference

12 November 2017

243-249

1 reference

https://scigraph.springernature.com/pub.10.1007/s00228-005-0080-0

12 November 2017

0 references

cites work

Risk of severe hepatotoxicity associated with antiretroviral therapy in the HIV-NAT Cohort, Thailand, 1996–2001

1 reference

12 December 2020

Management of chronic hepatitis C in HIV-infected patients

1 reference

12 December 2020

Immunological, virological and clinical response to highly active antiretroviral therapy treatment regimens in a complete clinic population. Royal Free Centre for HIV Medicine

1 reference

12 December 2020

Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study

1 reference

12 December 2020

Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection

1 reference

12 December 2020

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study

1 reference

12 December 2020

A review of goodness of fit statistics for use in the development of logistic regression models

1 reference

12 December 2020

Rates of spontaneous reporting of adverse drug reactions in France

1 reference

12 December 2020

Elevated Framingham risk score in HIV-positive patients on highly active antiretroviral therapy: results from a Norwegian study of 721 subjects

1 reference

12 December 2020

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

12 December 2020

Hepatotoxicity development during antiretroviral therapy containing protease inhibitors in patients with HIV: the role of hepatitis B and C virus infection

1 reference

12 December 2020

Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection

1 reference

12 December 2020

Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count > 350 × 106/l

1 reference

12 December 2020

Acute hepatitis in HIV-infected patients during ritonavir treatment

1 reference

12 December 2020

Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union. The European Pharmacovigilance Research Group

1 reference

12 December 2020

A cohort study of nevirapine tolerance in clinical practice: French Aquitaine Cohort, 1997-1999.

1 reference

12 December 2020

Incidence of and risk factors for severe hepatotoxicity associated with antiretroviral combination therapy

1 reference

12 December 2020

Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS.

1 reference

12 December 2020

HCV chronic hepatitis in patients with HIV: clinical management issues

1 reference

12 December 2020

Is reporting rate a good predictor of risks associated with drugs?

1 reference

12 December 2020

Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection

1 reference

12 December 2020

Hepatotoxicity after introduction of highly active antiretroviral therapy

1 reference

12 December 2020

Trends in spontaneous adverse drug reaction reports to the French pharmacovigilance system (1986-2001).

1 reference

12 December 2020

Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France

1 reference

12 December 2020

Adverse drug reactions: definitions, diagnosis, and management

1 reference

12 December 2020

Increased incidence of indinavir nephrolithiasis in patients with hepatitis B or C virus infection.

1 reference

12 December 2020

International Conference on Harmonisation; guidance on Addendum to E2C Clinical Safety Data Management: Periodic Safety Update Reports for Marketed Drugs; availability. Notice.

1 reference

12 December 2020

10.1007/S00228-005-0080-0

Identifiers

DOI

1 reference

12 November 2017

1 reference

PubMed ID

16416303